ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, giving promising breakthroughs across different health-related and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, more responsible substitute for therapeutic use